Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of novel indolyl-1,2,4-triazole hybrids as potent vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors with potential anti-renal cancer activity
Sami A. Al‐Hussain, Thoraya A. Farghaly, Magdi E. A. Zaki, et al.
Bioorganic Chemistry (2020) Vol. 105, pp. 104330-104330
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Target-based anticancer indole derivatives and insight into structure‒activity relationship: A mechanistic review update (2018–2021)
A M Dhiman, Rupam Sharma, Rajesh K. Singh
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 7, pp. 3006-3027
Open Access | Times Cited: 113
Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, in vitro and in silico studies
Dina I. A. Othman, Abdelrahman Hamdi, Samar S. Tawfik, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 44
Exploration of novel VEGFR2 tyrosine kinase inhibitors via design and synthesis of new alkylated indolyl-triazole Schiff bases for targeting breast cancer
Mohamed S. Nafie, Ahmed T. A. Boraei
Bioorganic Chemistry (2022) Vol. 122, pp. 105708-105708
Closed Access | Times Cited: 55
Structural modification strategies of triazoles in anticancer drug development
Qianwen Guan, Ziming Gao, Yuting Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116578-116578
Closed Access | Times Cited: 16
Novel small molecule inhibitors targeting renal cell carcinoma: Status, challenges, future directions
Lin Xiong, Ya Zhang, Jiaxing Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116158-116158
Open Access | Times Cited: 13
Recent Advances and Future Directions on Small Molecule VEGFR Inhibitors in Oncological Conditions
Amandeep Thakur, Mandeep Rana, Anshul Mishra, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116472-116472
Closed Access | Times Cited: 9
Recent advances in, and challenges of, anti-angiogenesis agents for tumor chemotherapy based on vascular normalization
Kai Wang, Qinhua Chen, Nanxin Liu, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 11, pp. 2743-2753
Closed Access | Times Cited: 44
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines as CDK2 inhibitors and anti-leukemia
Samar J. Almehmadi, Amani M.R. Alsaedi, Marwa F. Harras, et al.
Bioorganic Chemistry (2021) Vol. 117, pp. 105431-105431
Closed Access | Times Cited: 43
Synthesis and biological assessment of indole derivatives containing penta-heterocycles scaffold as novel anticancer agents towards A549 and K562 cells
Guanglong Zhang, Zhenhua Tang, Sili Fan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 19
Antineoplastic indole-containing compounds with potential VEGFR inhibitory properties
Dalia R. Aboshouk, Mohamed A. Youssef, Mohamed S. Bekheit, et al.
RSC Advances (2024) Vol. 14, Iss. 9, pp. 5690-5728
Open Access | Times Cited: 8
An updated review on 1,2,3-/1,2,4-triazoles: synthesis and diverse range of biological potential
Anirudh Pratap Singh Raman, M. Aslam, Amardeep Awasthi, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 7
Targeting the interplay between MMP-2, CA II and VEGFR-2 via new sulfonamide-tethered isomeric triazole hybrids; Microwave-assisted synthesis, computational studies and evaluation
Mohamed Reda Aouad, Meshal A. Almehmadi, Fawzia Faleh Albelwi, et al.
Bioorganic Chemistry (2022) Vol. 124, pp. 105816-105816
Closed Access | Times Cited: 28
Design and synthesis of new 2-oxoquinoxalinyl-1,2,4-triazoles as antitumor VEGFR-2 inhibitors
Merve Zengin, Oya Ünsal Tan, Reem K. Arafa, et al.
Bioorganic Chemistry (2022) Vol. 121, pp. 105696-105696
Closed Access | Times Cited: 23
Synthesis, anticancer activity, and molecular docking of new pyrazolo[1,5-a]pyrimidine derivatives
Aisha Hossan, Abdulmajeed F. Alrefaei, Hanadi A. Katouah, et al.
Journal of Saudi Chemical Society (2023) Vol. 27, Iss. 2, pp. 101599-101599
Open Access | Times Cited: 16
Discovery of novel benzimidazole derivatives as potent HDACs inhibitors against leukemia with (Thio)Hydantoin as zinc-binding moiety: Design, synthesis, enzyme inhibition, and cellular mechanistic study
Hanan Gaber Abdulwahab, Reda El‐Sayed Mansour, Thoraya A. Farghaly, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107284-107284
Closed Access | Times Cited: 5
Synthetic and Medicinal Perspective of 1,2,4‐Triazole as Anticancer Agents
Bhagyashri Rathod, Kapil Kumar
Chemistry & Biodiversity (2022) Vol. 19, Iss. 11
Closed Access | Times Cited: 22
Fluorinated azole anticancer drugs: Synthesis, elaborated structure elucidation and docking studies
Amani M.R. Alsaedi, Thoraya A. Farghaly, Mohamed R. Shaaban
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 5, pp. 103782-103782
Open Access | Times Cited: 21
Biologically Oriented Hybrids of Indole and Hydantoin Derivatives
К. А. Кочетков, Olga N. Gorunova, N. A. Bystrova
Molecules (2023) Vol. 28, Iss. 2, pp. 602-602
Open Access | Times Cited: 12
Synthesis of antimicrobial azoloazines and molecular docking for inhibitingCOVID‐19
Zeinab A. Muhammad, Thoraya A. Farghaly, Ismail Althagafi, et al.
Journal of Heterocyclic Chemistry (2021) Vol. 58, Iss. 6, pp. 1286-1301
Open Access | Times Cited: 27
Design of new hybrids indole/phthalimide/oxadiazole-1,2,3 triazole agents and their anticancer properties
Hanan A. Mohamed, Mohamed S. Bekheit, Ewies F. Ewies, et al.
Journal of Molecular Structure (2022) Vol. 1274, pp. 134415-134415
Closed Access | Times Cited: 19
Synthesis of new functionalized bioactive S-substituted indolyl-triazoles as cytotoxic and apoptotic agents through multi-targeted kinase inhibition
Ahmed T. A. Boraei, Mohamed S. Nafie, Assem Barakat, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108154-108154
Closed Access
Therapeutic Insights of Indole Scaffold‐Based Compounds as Protein Kinase Inhibitors
Dina H. Dawood
ChemistrySelect (2025) Vol. 10, Iss. 5
Open Access
Design and Synthesis of New Triazole‐Benzimidazole Derivatives as Potential PRMT5 Inhibitors
Katharu Srinivasa Rao, Kirankumar Nalla, C. Ramachandraiah, et al.
ChemistrySelect (2023) Vol. 8, Iss. 11
Closed Access | Times Cited: 9
Prospects for the search for new biologically active compounds among the derivatives of the heterocyclic system of 1,2,4-triazole.
Sameliuk Yurii, А. Г. Каплаушенко, Natalia NEDOREZANIUK, et al.
Hacettepe University Journal of the Faculty of Pharmacy (2022)
Open Access | Times Cited: 14
Design, Synthesis, Anticancer Activity and Docking Studies of Thiazole Linked Phenylsulfone Moiety as Cyclin-Dependent Kinase 2 (CDK2) Inhibitors
Thoraya A. Farghaly, Wedian A. Al-Hasani, Mona H. Ibrahim, et al.
Polycyclic aromatic compounds (2022) Vol. 43, Iss. 6, pp. 5001-5020
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top